Low-dose nafamostat mesilate ameliorates tissue injury and inhibits 5-hydroxytryptamine synthesis in the rat intestine after methotrexate administration
We aimed to clarify the effect of nafamostat mesilate (nafamostat) on intestinal mucositis as well as the potentiation of intestinal 5-hydroxytryptamine (5-HT) dynamics induced by methotrexate, an anti-cancer drug, in rats. Rats received intraperitoneal methotrexate at 12.5 mg/kg/day for 4 days. In...
Saved in:
Main Authors: | Takahiro Yamamoto (Author), Takuji Machida (Author), Chiho Tanno (Author), Shiori Hasebe (Author), Mayu Tamura (Author), Nanaka Kobayashi (Author), Sachiko Hiraide (Author), Naoya Hamaue (Author), Kenji Iizuka (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiac arrest caused by nafamostat mesilate
by: Hyo Shik Kim, et al.
Published: (2016) -
Nitric oxide plays a critical role in methotrexate-induced hyperplasia of enterochromaffin cells containing 5-hydroxytryptamine in rat small intestine
by: Yuho Takano, et al.
Published: (2019) -
Administration of cyclophosphamide to rats induces pica and potentiates 5-hydroxytryptamine synthesis in the intestine without causing severe intestinal injury
by: Akihisa Kamiya, et al.
Published: (2021) -
Nafamostat Mesilate Is an Extremely Potent Inhibitor of Human Tryptase
by: Shuji Mori, et al.
Published: (2003) -
Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
by: Ioanna Koniari, et al.
Published: (2017)